Southland Equity Partners LLC Boosts Holdings in CVS Health Co. (NYSE:CVS)

Southland Equity Partners LLC boosted its position in shares of CVS Health Co. (NYSE:CVS) by 44.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 4,985 shares of the pharmacy operator’s stock after purchasing an additional 1,523 shares during the quarter. Southland Equity Partners LLC’s holdings in CVS Health were worth $224,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Secure Asset Management LLC grew its holdings in shares of CVS Health by 13.8% during the fourth quarter. Secure Asset Management LLC now owns 33,271 shares of the pharmacy operator’s stock valued at $1,494,000 after buying an additional 4,024 shares during the last quarter. Donoghue Forlines LLC bought a new position in CVS Health in the 4th quarter valued at approximately $1,400,000. SG Americas Securities LLC boosted its stake in CVS Health by 47.2% during the 4th quarter. SG Americas Securities LLC now owns 28,801 shares of the pharmacy operator’s stock valued at $1,293,000 after purchasing an additional 9,234 shares during the last quarter. Perfromance Wealth Partners LLC bought a new stake in shares of CVS Health in the 4th quarter worth $475,000. Finally, Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of CVS Health by 17.6% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 1,089,654 shares of the pharmacy operator’s stock valued at $48,915,000 after purchasing an additional 163,148 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on CVS shares. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $60.00 to $66.00 in a report on Monday, November 18th. TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Barclays cut their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Piper Sandler dropped their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Finally, Truist Financial reduced their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Trading Up 1.6 %

Shares of CVS stock opened at $54.71 on Friday. The stock has a fifty day simple moving average of $51.21 and a two-hundred day simple moving average of $56.22. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The firm has a market capitalization of $68.84 billion, a PE ratio of 13.88, a PEG ratio of 0.80 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the company posted $2.21 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, analysts predict that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.86%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.